The relative mRNA expression of ATF3 in the glioma tissues of grade II, III and IV was 3.23±0.51, 5.24±0.43 and 6.37±0.45, respectively, significantly higher compared to the normal brain tissues (all P<0.05; Fig. 2A). The gene discussed is ATF3; the disease is central nervous system cancer.